Search results
Earnings call: Nektar Therapeutics optimistic on REZPEG and pipeline progress By Investing.com
Investing.com· 1 day agoNektar Therapeutics (NASDAQ:NKTR) reported a productive first quarter of 2024, focusing on their...
Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
Zacks via Yahoo Finance· 1 day agoNektar Therapeutics NKTR incurred an adjusted loss per share of 18 cents in first-quarter 2024,...
Jefferies raises Nektar Therapeutics stock target, maintains hold By Investing.com
Investing.com· 1 day agoJefferies, a well-known investment firm, has increased its price target on shares of Nektar...
Nektar Therapeutics (NKTR) First Quarter 2024 Earnings Overview
Guru Focus· 1 day agoOn May 9, 2024, Nektar Therapeutics (NKTR, Financial) disclosed its financial results for the first quarter ended March 31, 2024, through an 8-K filing. The biopharmaceutical ...
Nektar: Q1 Earnings Snapshot
Santa Maria Times· 2 days agoSAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Nektar Therapeutics (NKTR) on Thursday reported a loss of $36.8 million in its first quarter.
Nektar Therapeutics Reports First Quarter 2024 Financial Results
Char-Koosta News· 2 days agoNektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2024. Cash and investments in marketable securities at March 31, ...
